Evidence map›Paper›PMID 32266822›Full record

ArticleAmerican journal of physiology. Lung cellular and molecular physiology2020

Call for Papers: The Pathophysiology of COVID-19 and SARS-CoV-2 Infection.

Rory E Morty, John Ziebuhr

Abstract readEditorial
In one paragraph

Article in American journal of physiology. Lung cellular and molecular physiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Call for Papers: "In It for the Long Haul: Understanding the Lasting Impact of COVID-19 on Lung Health and Disease".American journal of physiology. Lung cellular and molecular physiology · 2022
    Article
  2. An American Physiological Society cross-journal Call for Papers on "The Physiology of Obesity".American journal of physiology. Lung cellular and molecular physiology · 2022
    Article
  3. Review
  4. Article
  5. World Lung Day 2020 at theAmerican journal of physiology. Lung cellular and molecular physiology · 2020
    Article
  6. SARS-CoV-2 (COVID-19) and cystic fibrosis.American journal of physiology. Lung cellular and molecular physiology · 2020
    Article
  7. Assessment of ACE inhibitors/angiotensin receptor blockers in COVID-19 patients.American journal of physiology. Lung cellular and molecular physiology · 2020
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Rory E MortyDepartment of Lung Development and Remodelling, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany.ORCID 0000-0003-0833-9749
John ZiebuhrInstitute of Medical Virology, Justus Liebig University Giessen, member of the German Center for Infection Research, Giessen, Germany.ORCID 0000-0002-5741-8825

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BetacoronavirusCoronavirus InfectionsManuscripts, Medical as TopicPandemicsPneumonia, ViralCOVID-19HumansSARS-CoV-2coronavirusCOVID-19pandemicpneumoniaSARS-CoV-2

Identifiers

PMID32266822
PMCPMC7200871

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.